Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

This grant supports exploratory, early-stage projects that identify undruggable target classes linked to human disease and develop methods or agents selective for those targets. It funds innovative strategies to modulate targets that cannot be addressed by established therapeutic types.